Medpace Holdings, Inc. Common Stock (MEDP) Financials
Key financial figures for Medpace Holdings, Inc. Common Stock (Q3 2026).
Medpace Holdings, Inc. reported revenue of $716.0 million for Q3 FY2026, up 8.5% from the same period a year earlier. Net income was $137.5 million, or $4.84 per share. Operating margin came to 23.12%, against 21.49% a year earlier. Free cash flow for the period was $196.4 million. Across the last 5 reported quarters, quarterly revenue has risen from $659.9 million in Q3 FY2025 to $716.0 million in Q3 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Medpace Holdings, Inc. are on the SentiSense financials page.
- Revenue
- $716M
- Net Income
- $137M
- EPS
- $4.92
- Total Assets
- $2.3B
- Operating Cash Flow
- $217M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $716M | $137M | $4.84 | 23.12% | $196M |
| Q2 FY2026 | $707M | $121M | $4.25 | 20.76% | $138M |
| Q1 FY2026 | $707M | $124M | $4.28 | 20.03% | $145M |
| Q4 FY2025 | $708M | $135M | $4.67 | 21.63% | $188M |
| Q3 FY2025 | $660M | $111M | $3.86 | 21.49% |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $2.5B | $451M | $15.28 | 21.14% | $682M |
| FY2024 | $2.1B | $404M | $12.63 | 21.19% | $572M |
| FY2023 | $1.9B | $283M | $8.88 | 17.86% | $397M |
Frequently asked questions
What was Medpace Holdings, Inc.'s revenue last quarter?
Medpace Holdings, Inc. reported revenue of $716.0 million for Q3 FY2026, up 8.5% from the same period a year earlier.
Is Medpace Holdings, Inc. profitable?
Yes. Medpace Holdings, Inc. reported net income of $137.5 million for Q3 FY2026, a net margin of 19.2% on revenue.
How has Medpace Holdings, Inc.'s margin trended?
Operating margin was 23.12% in Q3 FY2026, compared with 21.49% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Medpace Holdings, Inc. generate?
Medpace Holdings, Inc. generated free cash flow of $196.4 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Medpace Holdings, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.